{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:15:24Z","timestamp":1769814924519,"version":"3.49.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4452","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T22:04:32Z","timestamp":1439589872000},"page":"2045-2049","source":"Crossref","is-referenced-by-count":2,"title":["Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer"],"prefix":"10.2169","volume":"54","author":[{"given":"Masamichi","family":"Komatsu","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yasuo","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumitsu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tateishi","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Ushiki","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Urushihata","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Joetsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum 38: 458-466, 2009.","DOI":"10.1016\/j.semarthrit.2008.07.001"},{"key":"2","unstructured":"2. Karnan S, Krishnamoorthy V, Ethiraj P, Sathyanathan BP. Touraine-Solente-Gole syndrome: the complete form needs to be recognized. Indian J Nucl Med 27: 201-204, 2012."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Coury C. Hippocration fingers and hypertrophic osteoarthropathy. A study of 350 cases. Br J Dis Chest 54: 202-209, 1960.","DOI":"10.1016\/S0007-0971(60)80001-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Qian X, Qin J. Hypertrophic pulmonary osteoarthropathy with primary lung cancer. Oncol Lett 7: 2079-2082, 2014.","DOI":"10.3892\/ol.2014.2022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ito T, Goto K, Yoh K, et al. Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer. J Thorac Oncol 5: 976-980, 2010.","DOI":"10.1097\/JTO.0b013e3181dc1f3c"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566, 2007.","DOI":"10.1038\/nature05945"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 22: 508-515, 2009.","DOI":"10.1038\/modpathol.2009.2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Camidge DR, Kono SA, Flacco A, et al. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. Clin Cancer Res 15: 5581-5590, 2010.","DOI":"10.1158\/1078-0432.CCR-10-0851"},{"key":"9","unstructured":"9. Abe Y, Kurita S, Ohkubo Y, et al. A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor. Anticancer Res 22: 3485-3488, 2002."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Silveri F, De Angelis R, Argentati F, et al. Hypertrophic osteoarthropathy: endothelium and platelet function. Clin Rheumatol 15: 435-439, 1996.","DOI":"10.1007\/BF02229639"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dejean E, Renalier MH, Foisseau M, et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 25: 1882-1890, 2011.","DOI":"10.1038\/leu.2011.168"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sandler A, Herbst R. Combining targeted agents: blocking the epidermal growth factor and vascular endothelial growth factor pathways. Clin Cancer Res 12: 4421s-4425s, 2006.","DOI":"10.1158\/1078-0432.CCR-06-0796"},{"key":"13","unstructured":"13. Hara Y, Matsuura Y, Takiguchi H. Reversal of pulmonary hypertrophic osteoarthropathy in surgically treated lung cancer. Nihon Kokyuki Gakkai Zasshi 48: 966-971, 2010 (in Japanese, Abstract in English)."},{"key":"14","unstructured":"14. Hayashi M, Sekikawa A, Saijo A. Successful treatment of hypertrophic osteoarthropathy by gefitinib in a case with lung adenocarcinoma. Anticancer Res 25: 2435-2438, 2005."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/16\/54_54.4452\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:42:39Z","timestamp":1498239759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/16\/54_54.4452\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":14,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4452","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}